{"product_id":"epclusa-vel-100mg-sof-400mg-28-tab","title":"EPCLUSA - VELPATASVIR 100MG \/SOFOSBUVIR 400MG 28 TAB","description":"\u003ch2\u003eEPCLUSA (VELPATASVIR 100MG\/SOFOSBUVIR 400MG) 28 TABLETS\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eProduct Description:\u003c\/strong\u003e\u003cbr\u003eEPCLUSA is a prescription medication used to treat adults with chronic hepatitis C virus (HCV) genotype 1-6 infection. This single-tablet regimen combines 100mg of velpatasvir and 400mg of sofosbuvir, two antiviral medications that work in concert to inhibit HCV replication. EPCLUSA offers a ribavirin-free treatment option, suitable for use in a broad range of HCV patients, including those with compensated cirrhosis.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTechnician Specifications:\u003c\/strong\u003e\u003cbr\u003e- \u003cstrong\u003eActive Ingredients:\u003c\/strong\u003e Velpatasvir 100mg, Sofosbuvir 400mg\u003cbr\u003e- \u003cstrong\u003eFormulation:\u003c\/strong\u003e Fixed-dose combination tablet\u003cbr\u003e- \u003cstrong\u003ePackage Size:\u003c\/strong\u003e 28 tablets per bottle\u003cbr\u003e- \u003cstrong\u003eDosage:\u003c\/strong\u003e One tablet taken orally once daily with or without food\u003cbr\u003e- \u003cstrong\u003eTreatment Duration:\u003c\/strong\u003e Typically 12 weeks, may vary based on patient's clinical status\u003cbr\u003e- \u003cstrong\u003eStorage:\u003c\/strong\u003e Store at room temperature away from moisture and heat\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCommon Applications\/User Groups:\u003c\/strong\u003e\u003cbr\u003e- Adults with chronic HCV genotypes 1-6\u003cbr\u003e- Patients without cirrhosis or with compensated cirrhosis\u003cbr\u003e- Suitable for patients who are HCV treatment-naïve or treatment-experienced\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOverview of Gilead Sciences:\u003c\/strong\u003e\u003cbr\u003eGilead Sciences is a biopharmaceutical company that has established itself as a leader in the development of antiviral drugs, particularly in the treatment of HCV. With a commitment to advancing healthcare and an extensive research and development program, Gilead has brought to market several highly effective HCV therapies. Their authority in the product category is underscored by a robust portfolio of HCV treatments that have transformed the standard of care, offering cure rates exceeding 90% for many patient populations. Gilead's dedication to innovation, patient access, and support programs makes them a trusted supplier in the fight against chronic HCV infection.\u003c\/p\u003e","brand":"Gilead","offers":[{"title":"Default Title","offer_id":51689657139564,"sku":"PHA18767","price":14378.06,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0012\/8440\/7394\/files\/epclusa-velpatasvir-100mg-sofosbuvir-400mg-28-tab-gilead-59438876918124.jpg?v=1732142221","url":"https:\/\/checkout.medshop.com.au\/products\/epclusa-vel-100mg-sof-400mg-28-tab","provider":"Medshop Australia","version":"1.0","type":"link"}